Calixar Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 15
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $2.75M
Latest Deal Amount
  • Investors
  • 10

Calixar General Information

Description

Operator of a biotechnology company intended to preserve the original structure and function of membrane protein operations. The company engages in the production, extraction, stabilization, purification and crystallization of functional membrane proteins and antigens, by isolating them in a native conformation without mutations or deletions, enabling biotechnology companies to develop conformational antibodies and formulate new vaccines efficiently.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Laboratory Services (Healthcare)
Biotechnology
Primary Office
  • Bâtiment Laennec
  • 60 Avenue Rockefeller
  • 69008 Lyon
  • France
+33 04 00 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Calixar Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 13-Mar-2020 $2.75M 00.000 Completed Generating Revenue
3. Early Stage VC (Series A) 24-Feb-2015 00000 00.000 00.000 Completed Generating Revenue
2. Early Stage VC (Series A) 18-Jun-2012 $1.1M $1.1M 00.000 Completed Generating Revenue
1. Early Stage VC 01-Jan-2011 Completed Startup
To view Calixar’s complete valuation and funding history, request access »

Calixar Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class A Preference 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
Class A Preference 33,400 $1.134983 $28.37 $28.37 1x $28.37 28.17%
To view Calixar’s complete cap table history, request access »

Calixar Executive Team (5)

Name Title Board Seat Contact Info
Emmanuel Dejean Ph.D Co-Founder, Chairman, President and Chief Executive Officer
Anass Jawhari Chief Scientific Officer
Pierre Falson Co-Founder
To view Calixar’s complete executive team members history, request access »

Calixar Board Members (1)

Name Representing Role Since
Emmanuel Dejean Ph.D Calixar Co-Founder, Chairman, President and Chief Executive Officer 000 0000
To view Calixar’s complete board members history, request access »

Calixar Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Calixar Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Banque Populaire Lender/Debt Provider Minority 000 0000 000000 0
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
XAnge Private Equity Venture Capital Minority 000 0000 000000 0
Crealys Accelerator/Incubator Minority 000 0000 000000 0
Grenoble Angels Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »